Palatin Technologies, Inc. (PTN)
USD 0.75
(-9.64%)
USD 0.75
(-9.64%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -29.73 Million USD | -7.97% |
| 2023 | -27.54 Million USD | 23.08% |
| 2022 | -35.8 Million USD | -6.67% |
| 2021 | -33.56 Million USD | -49.98% |
| 2020 | -22.38 Million USD | -162.57% |
| 2019 | 35.77 Million USD | 44.81% |
| 2018 | 24.7 Million USD | 285.3% |
| 2017 | -13.33 Million USD | 74.22% |
| 2016 | -51.71 Million USD | -192.73% |
| 2015 | -17.66 Million USD | -26.83% |
| 2014 | -13.92 Million USD | 33.24% |
| 2013 | -20.86 Million USD | -20.92% |
| 2012 | -17.25 Million USD | -34.62% |
| 2011 | -12.81 Million USD | -614.97% |
| 2010 | -1.79 Million USD | 62.67% |
| 2009 | -4.8 Million USD | 66.61% |
| 2008 | -14.38 Million USD | 48.17% |
| 2007 | -27.75 Million USD | 4.17% |
| 2006 | -28.95 Million USD | -101.69% |
| 2005 | -14.35 Million USD | 45.44% |
| 2004 | -26.31 Million USD | -27.97% |
| 2003 | -20.56 Million USD | -27.43% |
| 2002 | -16.13 Million USD | -52.26% |
| 2001 | -10.59 Million USD | -29.52% |
| 2000 | -8.18 Million USD | 31.8% |
| 1999 | -12 Million USD | -21.21% |
| 1998 | -9.9 Million USD | -86.79% |
| 1997 | -5.3 Million USD | -54.07% |
| 1996 | -3.44 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -5.88 Million USD | 45.04% |
| 2024 Q4 | -8.25 Million USD | 2.2% |
| 2024 Q3 | -8.43 Million USD | -7.54% |
| 2024 Q2 | -7.84 Million USD | -33.21% |
| 2023 FY | -27.54 Million USD | 23.08% |
| 2023 Q3 | -6.99 Million USD | -391.4% |
| 2023 Q2 | -1.42 Million USD | 82.75% |
| 2023 Q1 | -8.25 Million USD | 35.34% |
| 2023 Q4 | -10.71 Million USD | -53.11% |
| 2022 FY | -35.8 Million USD | -6.67% |
| 2022 Q1 | -7.11 Million USD | 48.96% |
| 2022 Q2 | -8.68 Million USD | -22.13% |
| 2022 Q3 | -7.44 Million USD | 14.32% |
| 2022 Q4 | -12.76 Million USD | -71.54% |
| 2021 Q1 | -3.94 Million USD | 46.01% |
| 2021 FY | -33.56 Million USD | -49.98% |
| 2021 Q2 | -9.99 Million USD | -153.55% |
| 2021 Q3 | -5.72 Million USD | 42.66% |
| 2021 Q4 | -13.93 Million USD | -143.2% |
| 2020 Q3 | -5.38 Million USD | -2.64% |
| 2020 Q1 | -4.5 Million USD | -108.62% |
| 2020 Q2 | -5.24 Million USD | -16.5% |
| 2020 Q4 | -7.29 Million USD | -35.61% |
| 2020 FY | -22.38 Million USD | -162.57% |
| 2019 Q2 | -5.04 Million USD | 11.26% |
| 2019 Q1 | -5.68 Million USD | -148.12% |
| 2019 Q3 | -5.72 Million USD | -13.58% |
| 2019 Q4 | 52.22 Million USD | 1011.88% |
| 2019 FY | 35.77 Million USD | 44.81% |
| 2018 Q2 | 3.03 Million USD | -71.42% |
| 2018 Q1 | 10.6 Million USD | -20.37% |
| 2018 FY | 24.7 Million USD | 285.3% |
| 2018 Q3 | -739.18 Thousand USD | -124.39% |
| 2018 Q4 | 11.8 Million USD | 1697.45% |
| 2017 Q3 | -3.56 Million USD | 64.46% |
| 2017 Q4 | 13.31 Million USD | 473.54% |
| 2017 FY | -13.33 Million USD | 74.22% |
| 2017 Q2 | -10.02 Million USD | 23.16% |
| 2017 Q1 | -13.05 Million USD | 2.28% |
| 2016 Q3 | -12.69 Million USD | 4.17% |
| 2016 Q4 | -13.35 Million USD | -5.2% |
| 2016 FY | -51.71 Million USD | -192.73% |
| 2016 Q2 | -13.24 Million USD | -6.77% |
| 2016 Q1 | -12.4 Million USD | -2.68% |
| 2015 Q4 | -12.08 Million USD | -32.08% |
| 2015 Q2 | 2.77 Million USD | 249.42% |
| 2015 FY | -17.66 Million USD | -26.83% |
| 2015 Q3 | -9.15 Million USD | -429.54% |
| 2015 Q1 | 794.67 Thousand USD | 118.4% |
| 2014 Q3 | -1.51 Million USD | 58.05% |
| 2014 Q2 | -3.6 Million USD | 19.66% |
| 2014 Q1 | -4.48 Million USD | 4.85% |
| 2014 FY | -13.92 Million USD | 33.24% |
| 2014 Q4 | -4.31 Million USD | -185.53% |
| 2013 Q3 | -4.01 Million USD | -139.59% |
| 2013 Q4 | -4.71 Million USD | -17.5% |
| 2013 FY | -20.86 Million USD | -20.92% |
| 2013 Q1 | -10.45 Million USD | -98.98% |
| 2013 Q2 | -1.67 Million USD | 83.97% |
| 2012 FY | -17.25 Million USD | -34.62% |
| 2012 Q4 | -5.25 Million USD | 12.75% |
| 2012 Q3 | -6.02 Million USD | -129.39% |
| 2012 Q2 | -2.62 Million USD | 21.76% |
| 2012 Q1 | -3.35 Million USD | -1.37% |
| 2011 FY | -12.81 Million USD | -614.97% |
| 2011 Q4 | -3.3 Million USD | 13.05% |
| 2011 Q3 | -3.8 Million USD | -245.83% |
| 2011 Q2 | -1.1 Million USD | 76.08% |
| 2011 Q1 | -4.6 Million USD | -8.59% |
| 2010 Q4 | -4.23 Million USD | -109.62% |
| 2010 Q2 | 4.5 Million USD | 12245.89% |
| 2010 Q1 | -37.06 Thousand USD | 81.52% |
| 2010 FY | -1.79 Million USD | 62.67% |
| 2010 Q3 | -2.02 Million USD | -144.89% |
| 2009 FY | -4.8 Million USD | 66.61% |
| 2009 Q2 | -417.36 Thousand USD | 90.25% |
| 2009 Q3 | 98.17 Thousand USD | 123.52% |
| 2009 Q4 | -200.53 Thousand USD | -304.25% |
| 2009 Q1 | -4.28 Million USD | 18.31% |
| 2008 FY | -14.38 Million USD | 48.17% |
| 2008 Q1 | -246.76 Thousand USD | 95.96% |
| 2008 Q2 | -3.78 Million USD | -1433.5% |
| 2008 Q3 | -5.11 Million USD | -35.07% |
| 2008 Q4 | -5.24 Million USD | -2.56% |
| 2007 Q1 | -8.43 Million USD | -7.1% |
| 2007 FY | -27.75 Million USD | 4.17% |
| 2007 Q3 | -6.72 Million USD | -3.58% |
| 2007 Q2 | -6.48 Million USD | 23.09% |
| 2007 Q4 | -6.1 Million USD | 9.18% |
| 2006 FY | -28.95 Million USD | -101.69% |
| 2006 Q2 | -7.44 Million USD | -23.33% |
| 2006 Q4 | -7.87 Million USD | -3.62% |
| 2006 Q3 | -7.6 Million USD | -2.13% |
| 2006 Q1 | -6.03 Million USD | -18.54% |
| 2005 Q1 | -3.03 Million USD | 56.46% |
| 2005 Q2 | -2.28 Million USD | 24.77% |
| 2005 Q3 | -3.94 Million USD | -72.33% |
| 2005 FY | -14.35 Million USD | 45.44% |
| 2005 Q4 | -5.09 Million USD | -29.22% |
| 2004 FY | -26.31 Million USD | -27.97% |
| 2004 Q2 | -4.59 Million USD | 31.68% |
| 2004 Q3 | -8.02 Million USD | -74.87% |
| 2004 Q4 | -6.98 Million USD | 13.04% |
| 2004 Q1 | -6.71 Million USD | -3.97% |
| 2003 Q2 | -4.35 Million USD | -6.17% |
| 2003 Q4 | -6.46 Million USD | -14.35% |
| 2003 Q3 | -5.65 Million USD | -29.86% |
| 2003 Q1 | -4.09 Million USD | 18.5% |
| 2003 FY | -20.56 Million USD | -27.43% |
| 2002 Q3 | -4.26 Million USD | -13.14% |
| 2002 FY | -16.13 Million USD | -52.26% |
| 2002 Q1 | -3.6 Million USD | 7.73% |
| 2002 Q2 | -3.77 Million USD | -4.72% |
| 2002 Q4 | -5.02 Million USD | -17.83% |
| 2001 FY | -10.59 Million USD | -29.52% |
| 2001 Q4 | -3.9 Million USD | -47.47% |
| 2001 Q3 | -2.64 Million USD | -45.05% |
| 2001 Q2 | -1.82 Million USD | 17.86% |
| 2001 Q1 | -2.22 Million USD | -2.6% |
| 2000 Q4 | -2.16 Million USD | -19.79% |
| 2000 Q2 | -2.8 Million USD | -100.0% |
| 2000 Q3 | -1.8 Million USD | 35.43% |
| 2000 Q1 | -1.4 Million USD | 64.1% |
| 2000 FY | -8.18 Million USD | 31.8% |
| 1999 Q4 | -3.9 Million USD | -30.0% |
| 1999 Q1 | -3 Million USD | 9.09% |
| 1999 Q2 | -2.2 Million USD | 26.67% |
| 1999 FY | -12 Million USD | -21.21% |
| 1999 Q3 | -3 Million USD | -36.36% |
| 1998 Q1 | -2 Million USD | -16.96% |
| 1998 FY | -9.9 Million USD | -86.79% |
| 1998 Q4 | -3.3 Million USD | -37.5% |
| 1998 Q2 | -2.2 Million USD | -10.0% |
| 1998 Q3 | -2.4 Million USD | -9.09% |
| 1997 Q4 | -1.71 Million USD | -46.15% |
| 1997 Q1 | -1.05 Million USD | 0.0% |
| 1997 FY | -5.3 Million USD | -54.07% |
| 1997 Q3 | -1.17 Million USD | -17.0% |
| 1997 Q2 | -1 Million USD | 4.76% |
| 1996 FY | -3.44 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AIM ImmunoTech Inc. | -28.96 Million USD | -2.673% |
| Ampio Pharmaceuticals, Inc. | -8.63 Million USD | -244.487% |
| Armata Pharmaceuticals, Inc. | -69.04 Million USD | 56.932% |
| Actinium Pharmaceuticals, Inc. | -48.81 Million USD | 39.088% |
| Azitra, Inc. | -11.28 Million USD | -163.53% |
| Can-Fite BioPharma Ltd. | -7.63 Million USD | -289.522% |
| Chromocell Therapeutics Corporation | -7.38 Million USD | -302.885% |
| Calidi Biotherapeutics, Inc. | -29.21 Million USD | -1.78% |
| CEL-SCI Corporation | -32.36 Million USD | 8.125% |
| iBio, Inc. | -24.9 Million USD | -19.389% |
| Lineage Cell Therapeutics, Inc. | -21.48 Million USD | -38.398% |
| MAIA Biotechnology, Inc. | -19.77 Million USD | -50.388% |
| Matinas BioPharma Holdings, Inc. | -22.94 Million USD | -29.614% |
| Navidea Biopharmaceuticals, Inc. | -15.17 Million USD | -95.927% |
| NovaBay Pharmaceuticals, Inc. | -9.64 Million USD | -208.466% |
| NanoViricides, Inc. | -8.29 Million USD | -258.519% |
| Oragenics, Inc. | -20.65 Million USD | -43.961% |
| BiomX Inc. | -26.16 Million USD | -13.631% |
| BiomX Inc. | -26.16 Million USD | -13.631% |
| Protalix BioTherapeutics, Inc. | 8.31 Million USD | 457.749% |
| Scorpius Holdings, Inc. | -45.21 Million USD | 34.237% |